SRPTSarepta Therapeutics, Inc.

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+67.3% YoY

Gross Profit

$2M6.7% margin

Operating Income

-$21M-71.2% margin

Net Income

-$32M-109.4% margin

EPS (Diluted)

$-1.74

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$46M

Total Liabilities

$49M

Stockholders' Equity

-$3M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$18M	+67.3%
Gross Profit	$2M	$18M	-88.8%
Operating Income	-$21M	-$16M	-35.0%
Net Income	-$32M	-$25M	-27.9%

SRPT FY 2010 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena